Drawing for GRAIL

USPTO serial 87978114

GRAIL

Reviewed by CopyMark Law Group

Reg. 5547616Status 704Registered
Filing date
Status date
Registration date
Aug 21, 2018
Examiner
LIU, PHILIP HUAI-EN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active. Follow Madrid and USPTO deadlines for the next renewal cycle.

Status 704: Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active.

Need help with GRAIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Donald A Thompson

Donald A Thompson THOMPSON & CO.595 Pacific Ave., 4th FloorSan Francisco, CA 94133United States

Goods and services

ClassDescriptionStatusFirst use
001[ assays, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; diagnostic or screening assays, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; reagents for medical and genetic research use; chemical reagents and diagnostic preparations for clinical or medical laboratory use ]SECTION 8 - CANCELLEDFeb 8, 2017
005[ Medical diagnostic reagents and medical diagnostic kits comprised of medical diagnostic reagents; reagents for medical use and ] medical diagnostics or screening kits comprised of reagents for medical diagnostics and screening use [ ; reagents for use in genetic testing for medical and medical diagnostic purposes; diagnostic preparations for medical purposes; assays, reagents, enzymes, and nucleotides for medical or clinical diagnostics or screening purposes; diagnostic assays, reagents, enzymes, and nucleotides for medical or clinical purposes ]ACTIVEFeb 8, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 8, 2025NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jun 8, 20258.PRREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED—
Jun 8, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 21, 2025ES8RTEAS SECTION 8 RECEIVED—
Aug 29, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 21, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 18, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 18, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 18, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 18, 2022WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Feb 18, 2022WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Sep 27, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 27, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 27, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 21, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 20, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 19, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 18, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 18, 2018DPCCDIVISIONAL PROCESSING COMPLETE—
Jul 12, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 28, 2018IUAFUSE AMENDMENT FILED—
Jun 28, 2018DRRRDIVISIONAL REQUEST RECEIVED—
Jun 28, 2018ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Jun 28, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 9, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 7, 2018EX2GSOU EXTENSION 2 GRANTED—
May 7, 2018EXT2SOU EXTENSION 2 FILED—
May 7, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 3, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 1, 2017EX1GSOU EXTENSION 1 GRANTED—
Nov 1, 2017EXT1SOU EXTENSION 1 FILED—
Nov 1, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 9, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 13, 2017CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 13, 2017COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 14, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 14, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 22, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 1, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 25, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jan 25, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 25, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 25, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 18, 2017DOCKASSIGNED TO EXAMINER—
Dec 13, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 10, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance